Nutrition Fit's answer: With an end goal to additionally investigating the remedial capability of host eEF1A as an objective for the treatment of COVID-19, we assessed the eEF1A inhibitor Plitidepsin (aplidin), which has restricted clinical endorsement for the treatment of different myeloma. Pli...